FR2550800B1 - Vecteur plasmide ameliore et son utilisation - Google Patents

Vecteur plasmide ameliore et son utilisation

Info

Publication number
FR2550800B1
FR2550800B1 FR8412103A FR8412103A FR2550800B1 FR 2550800 B1 FR2550800 B1 FR 2550800B1 FR 8412103 A FR8412103 A FR 8412103A FR 8412103 A FR8412103 A FR 8412103A FR 2550800 B1 FR2550800 B1 FR 2550800B1
Authority
FR
France
Prior art keywords
region
plasmid vector
escherichia coli
improved plasmid
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8412103A
Other languages
English (en)
Other versions
FR2550800A1 (fr
Inventor
Kazuhiro Ohsuye
Shoji Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of FR2550800A1 publication Critical patent/FR2550800A1/fr
Application granted granted Critical
Publication of FR2550800B1 publication Critical patent/FR2550800B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
FR8412103A 1983-07-19 1984-07-19 Vecteur plasmide ameliore et son utilisation Expired FR2550800B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58132524A JP2551746B2 (ja) 1983-07-19 1983-07-19 改良プラスミドベクタ−およびその利用

Publications (2)

Publication Number Publication Date
FR2550800A1 FR2550800A1 (fr) 1985-02-22
FR2550800B1 true FR2550800B1 (fr) 1988-05-13

Family

ID=15083315

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8412103A Expired FR2550800B1 (fr) 1983-07-19 1984-07-19 Vecteur plasmide ameliore et son utilisation

Country Status (16)

Country Link
US (1) US5955307A (fr)
EP (1) EP0134673B1 (fr)
JP (1) JP2551746B2 (fr)
KR (1) KR850001286A (fr)
AT (1) ATE68206T1 (fr)
AU (1) AU575331B2 (fr)
CA (1) CA1338900C (fr)
CH (1) CH666284A5 (fr)
DE (1) DE3485148D1 (fr)
FR (1) FR2550800B1 (fr)
GB (1) GB2143535B (fr)
IE (1) IE57985B1 (fr)
IL (1) IL72449A (fr)
MX (1) MX7726E (fr)
NZ (1) NZ208942A (fr)
ZA (1) ZA845543B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60172999A (ja) * 1983-12-20 1985-09-06 Suntory Ltd 新規な塩基性ポリペプチドおよびその製造法
DK156072C (da) * 1985-04-03 1989-11-06 Nordisk Gentofte Syntetisk dna-sekvens indeholdende et ribosombindingssted
US5391485A (en) * 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
WO1987002037A1 (fr) * 1985-09-26 1987-04-09 Genetics Institute, Inc. Proteines tensio-actives pulmonaires
JPS63102695A (ja) * 1986-10-20 1988-05-07 Chisso Corp 大腸菌の菌体外分泌ベクタ−を用いる発光蛋白エクオリンの製造法
JP2577124Y2 (ja) * 1994-08-29 1998-07-23 エヌティエヌ株式会社 スライド装置
JP2007519422A (ja) 2004-02-02 2007-07-19 アンブレツクス・インコーポレイテツド 修飾されたヒト四螺旋バンドルポリペプチド及びそれらの使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009930B2 (fr) * 1978-10-10 1988-08-24 The Board Of Trustees Of The Leland Stanford Junior University DNA recombinant, méthode pour sa préparation et production de protéines étrangères par des hôtes unicellulaires le contenant
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
CA1200773A (fr) * 1980-02-29 1986-02-18 William J. Rutter Liens d'expression
US4315852A (en) * 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria
DK582381A (da) * 1981-01-02 1982-07-03 Univ New York Remkombinat plasmid til anvendelse ved bakteriel kloning
JPS589687A (ja) * 1981-06-17 1983-01-20 セルテク　リミテッド ポリペプチドの生産方法
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS5869897A (ja) * 1981-10-20 1983-04-26 Gakuzo Tamura Ｄｎａ遺伝子
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4863855A (en) * 1982-05-14 1989-09-05 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
EP0095361B1 (fr) * 1982-05-25 1989-07-26 Eli Lilly And Company Vecteurs de clonage pour l'expression de protéine exogène
US4443511A (en) * 1982-11-19 1984-04-17 W. L. Gore & Associates, Inc. Elastomeric waterproof laminate
US4921699A (en) * 1983-06-01 1990-05-01 Hoffman-La Roche Inc. Polypeptides having interferon activity

Also Published As

Publication number Publication date
MX7726E (es) 1991-02-15
IL72449A0 (en) 1984-11-30
DE3485148D1 (de) 1991-11-14
JP2551746B2 (ja) 1996-11-06
CA1338900C (fr) 1997-02-11
JPS6024187A (ja) 1985-02-06
KR850001286A (ko) 1985-03-18
FR2550800A1 (fr) 1985-02-22
CH666284A5 (fr) 1988-07-15
EP0134673A1 (fr) 1985-03-20
NZ208942A (en) 1988-10-28
IE57985B1 (en) 1993-06-02
AU575331B2 (en) 1988-07-28
GB8418273D0 (en) 1984-08-22
ATE68206T1 (de) 1991-10-15
AU3078684A (en) 1985-01-24
GB2143535B (en) 1987-09-03
US5955307A (en) 1999-09-21
IL72449A (en) 1993-07-08
ZA845543B (en) 1985-03-27
IE841853L (en) 1985-01-19
EP0134673B1 (fr) 1991-10-09
GB2143535A (en) 1985-02-13

Similar Documents

Publication Publication Date Title
ATE91714T1 (de) Transformation von trichoderma.
ES522762A0 (es) "procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines"
NO882763D0 (no) Humant apolipoprotein ai og variantform av samme uttrykt i escherichia coli.
DE3380262D1 (en) Cloning vectors for expression of exogenous protein
GB2147585B (en) Cdna clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity and/or mast cell growth factor activity
PT90321A (pt) Processo para a preparacao de polipeptideos de veneno de vibora
FR2550800B1 (fr) Vecteur plasmide ameliore et son utilisation
ES8900142A1 (es) Un procedimiento para aislar el plasmido it335
DE3684650D1 (de) Klonierung und charakterisierung des rinder-interleukin-2-gens.
ATE77834T1 (de) Human-parathyroidhormon (human-pth) produzierende hybridvektor.
ATE43139T1 (de) Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon.
ES8800353A1 (es) Procedimiento de clonacion de factor humano viii-r.
DK0576674T3 (da) Hidtil ukendt plasmid
IT1149394B (it) Procedimento per la produzione di un polipeptide eterologo mediante espressione di un vettore di clonazione ricombinante, vettore impiegato e microarganismo ospite cosi' trasformato
IL68753A0 (en) Cloning vectors for expression of exogenous protein

Legal Events

Date Code Title Description
ST Notification of lapse